Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury

Journal of Infectious Diseases

Volumn 181, Issue 6, 2000, Pages 1964-1970

  Takala, Annika ^a   Lähdevirta, Juhani ^b   Jansson, Sten Erik ^a   Vapalahti, Olli ^c   Orpana, Arto ^a   Karonen, Sirkka Liisa ^a   Repo, Heikki ^b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FLOW CYTOMETRY; HEMORRHAGIC FEVER; HUMAN; HYPOTENSION; KIDNEY DISEASE; LUNG INJURY; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PUUMALA VIRUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; E-SELECTIN; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; HYPOTENSION; INFLAMMATION; KIDNEY DISEASES; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; THROMBOCYTOPENIA;

EID: 0034089252     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315522     Document Type: Article

References (37)

1. 1. Kanerva M, Mustonen J, Vaheri A. Pathogenesis of Puumala and other Hantavirus infections. Rev Med Virol 1998; 8:67-86.
2. 2. Valtonen M, Kauppila M, Kotilainen P, et al. Four fatal cases of nephropathia epidemica. Scand J Infect Dis 1995; 27:515-7.
3. 3. Cosgriff TM. Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 1991; 13: 97-107.
4. 4. Lähdevirta J. Clinical features of HFRS in Scandinavia as compared with East Asia. Scand J Infect Dis 1982;(Suppl):36:S93-S95.
5. 5. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994; 330:949-55.
6. 6. Hjelle B, Goade D, Torrez-Martinez N, et al. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection with Bayou hantavirus. Clin Infect Dis 1996; 23:495-500.
7. 7. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994; 26:7-13.
8. 8. Linderholm M, Billström Ȧ, Settergren B, Tärnvik A. Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection 1992; 20:263-6.
9. 9. Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol 1996; 46:369-78.
10. 10. Lähdevirta J. Nephropathia epidemica in Finland: a clinical, histological and epidemiological study. Ann Clin Res 1971; 3:1-54.
11. 11. The ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-55.
12. 12. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996; 24:163-72.
13. 13. Giles RB, Sheedy JA, Edman CN, et al. The sequelae of epidemic hemorrhagic fever with a note on causes of death. Am J Med 1954; 16:629-38.
14. 14. Linderholm M, Ahlm C, Settergren B, Waage A, Tärnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-α, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996; 173:38-43.
15. 15. Takala A, Jousela I, Olkkola KT, et al. Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency. Clin Sci (Colch) 1999; 96:287-95.
16. 16. Takala A, Jousela I, Jansson S-E, et al. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci 1999; 97:529-38.
17. 17. Hedman K, Vaheri A, Brummer-Korvenkontio M. Rapid diagnosis of hantavirus disease with an IgG avidity assay. Lancet 1991; 338:1353-6.
18. 18. Repo H, Jansson S-E, Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993; 164:193-202.
19. 19. Repo H, Jansson S-E, Leirisalo-Repo M. Anticoagulant selection influences flow cytometric determination of Cd11b upregulation in vivo and ex vivo. J Immunol Methods 1995; 185:65-79.
20. 2) upregulation on neutrophils and monocytes after coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg 1996; 30:141-8.
21. 21. Lähdevirta J. The minor problem of hemostatic impairment in nephropathia epidemica, the mild Scandinavian form of hemorrhagic fever with renal syndrome. Rev Infect Dis 1989; 11(Suppl 4):S860-3.
22. 22. Torre D, Zeroli C, Giola M, et al. Serum levels of interleukin-1α, interleukin-1β, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 1994; 18:194-8.
23. 23. Hornef MW, Wagner HJ, Kruse A, Kirchner H. Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo. Clin Diagn Lab Immunol 1995; 2:209-13.
24. 24. Alberti A, Chemello L, Fattovich G, et al. Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis. Dig Dis Sci 1989; 34: 1559-63.
25. 25. Biglino A, Sinicco A, Forno B, et al. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol 1996; 78:61-69.
26. 26. Marklund G, Lundberg C, Nord CE, Ernberg I. Evidence of tinidazole interference in the oropharyngeal inflammatory process during infectious mononucleosis. Scand J Infect Dis 1986; 18:503-10.
27. 27. Dagan R, Powell KR. Postanginal sepsis following infectious mononucleosis. Arch Intern Med 1987; 147:1581-3.
28. 28. Mustonen J, Helin H, Pietilä K, Brummer-Korvenkontio M, Vaheri A. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol 1994; 41:121-6.
29. 29. Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 1996; 78:47-55.
30. 30. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Pathol 1995; 146: 552-79.
31. 31. Linderholm M, Bjermer L, Juto P, et al. Local host response in the lower respiratory tract in nephropathia epidemica. Scand J Infect Dis 1993; 25: 639-46.
32. 32. Krakauer T. Induction of CC chemokines in human peripheral blood mononuclear cells by staphylococcal exotoxins and its prevention by pentoxifylline. J Leukoc Biol 1999; 66:158-64.
33. 3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA 1998; 95:7074-9.
34. 3 integrins. J Virol 1999; 73:3951-9.
35. 35. Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 1987; 84:6471-5.
36. 3 integrin, essential to formation of osteoclast-like multinucleated cells. J Cell Sci 1998; 111:2563-74.
37. 37. Hermann P, Armant M, Brown E, et al. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J Cell Biol 1999; 144:767-75.